Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch [Yahoo! Finance]
Morgan Stanley (MS)
Last morgan stanley earnings: 4/16 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
morganstanley.com/about-us-ir
Company Research
Source: Yahoo! Finance
TheFly reported on January 8 that H.C. Wainwright analyst Robert Burns raised his price target on EXEL to $52 from $49 while maintaining a Buy rating after the company announced a strategic collaboration with Natera. According to Burns, investor sentiment around zanzalintinib's commercial potential across several tumor indications will be the primary near-to medium-term value driver. On the same day, Morgan Stanley downgraded Exelixis, Inc. (NASDAQ:EXEL) to Equal Weight from Overweight and raised its price target to $48 from $45. According to the firm, the stock is currently trading barely 10% below the updated goal after a roughly 28% increase in share price over the prior year. Zanzalintinib will be commercially available for a number of cancer indications for the first time in 2026, according to Morgan Stanley, and its valuation already accounts for related catalytic events. On January 11, EXEL reported preliminary 2025 revenues of about $2.32 billion in a business update that
Show less
Read more
Impact Snapshot
Event Time:
MS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MS alerts
High impacting Morgan Stanley news events
Weekly update
A roundup of the hottest topics
MS
News
- Fewer headwinds, better appetite in restuarant sector — Morgan Stanley [Seeking Alpha]Seeking Alpha
- Morgan Stanley sees improving fundamentals driving small-cap outperformance [Yahoo! Finance]Yahoo! Finance
- Morgan Stanley Real Estate Investing Acquires San Francisco Bay Area Advanced Manufacturing Facility for $110 MillionBusiness Wire
- Italgas downgraded to Hold from Buy at Deutsche Bank [Yahoo! Finance]Yahoo! Finance
- I owe you an apology, small cap stocks. I wasn't really familiar with your game. [Business Insider]Business Insider
MS
Earnings
- 1/15/26 - Beat
MS
Sec Filings
- 1/20/26 - Form 424B2
- 1/20/26 - Form 424B2
- 1/20/26 - Form 424B2
- MS's page on the SEC website